RESUMO
BACKGROUND: Pyruvate dehydrogenase complex (PDHc) deficiencies are an important cause of primary lactic acidosis. Most cases result from mutations in the X-linked gene for the pyruvate dehydrogenase E1α subunit (PDHA1) while a few cases result from mutations in genes for E1ß (PDHB), E2 (DLAT), E3 (DLD) and E3BP (PDHX) subunits or PDH-phosphatase (PDP1). AIM: To report molecular characterization of 82 PDHc-deficient patients and analyze structural effects of novel missense mutations in PDHA1. METHODS: PDHA1 variations were investigated first, by exon sequencing using a long range PCR product, gene dosage assay and cDNA analysis. Mutation scanning in PDHX, PDHB, DLAT and DLD cDNAs was further performed in unsolved cases. Novel missense mutations in PDHA1 were located on the tridimensional model of human E1 protein to predict their possible functional consequences. RESULTS: PDHA1 mutations were found in 30 girls and 35 boys. Three large rearrangements, including two contiguous gene deletion syndrome were identified. Novel missense, frameshift and splicing mutations were also delineated and a nonsense mutation in a mosaic male. Mutations p.Glu75Ala, p.Arg88Ser, p.Arg119Trp, p.Gly144Asp, p.Pro217Arg, p.Arg235Gly, p.Tyr243Cys, p.Tyr243Ser, p.Arg245Gly, p.Pro250Leu, p.Gly278Arg, p.Met282Val, p.Gly298Glu in PDHA1 were predicted to impair active site channel conformation or subunit interactions. Six out of the seven patients with PDHB mutations displayed the recurrent p.Met101Val mutation; 9 patients harbored PDHX mutations and one patient DLD mutations. CONCLUSION: We provide an efficient stepwise strategy for mutation screening in PDHc genes and expand the growing list of PDHA1 mutations analyzed at the structural level.
Assuntos
Substituição de Aminoácidos , Piruvato Desidrogenase (Lipoamida)/genética , Doença da Deficiência do Complexo de Piruvato Desidrogenase/genética , Adolescente , Sequência de Bases , Domínio Catalítico , Células Cultivadas , Criança , Pré-Escolar , Feminino , Fibroblastos/enzimologia , Fibroblastos/metabolismo , Dosagem de Genes , Humanos , Ligação de Hidrogênio , Mutação INDEL , Lactente , Recém-Nascido , Masculino , Dados de Sequência Molecular , Complexo Piruvato Desidrogenase/química , Complexo Piruvato Desidrogenase/genética , Complexo Piruvato Desidrogenase/metabolismo , Análise de Sequência de DNARESUMO
PURPOSE: The mutations responsible for Best vitelliform macular dystrophy (BVMD) are found in a gene called VMD2. The VMD2 gene encodes a transmembrane protein named bestrophin-1 (hBest1) which is a Ca(2+)-sensitive chloride channel. This study was performed to identify disease-specific mutations in 27 patients with BVMD. Because this disease is characterised by an alteration in Cl(-) channel function, patch clamp analysis was used to test the hypothesis that one of the VMD2 mutated variants causes the disease. METHODS: Direct sequencing analysis of the 11 VMD2 exons was performed to detect new abnormal sequences. The mutant of hBest1 was expressed in HEK-293 cells and the associated Cl(-) current was examined using whole-cell patch clamp analysis. RESULTS: Six new VMD2 mutations were identified, located exclusively in exons four, six and eight. One of these mutations (Q293H) was particularly severe. Patch clamp analysis of human embryonic kidney cells expressing the Q293H mutant showed that this mutant channel is non-functional. Furthermore, the Q293H mutant inhibited the function of wild-type bestrophin-1 channels in a dominant negative manner. CONCLUSIONS: This study provides further support for the idea that mutations in VMD2 are a necessary factor for Best disease. However, because variable expressivity of VMD2 was observed in a family with the Q293H mutation, it is also clear that a disease-linked mutation in VMD2 is not sufficient to produce BVMD. The finding that the Q293H mutant does not form functional channels in the membrane could be explained either by disruption of channel conductance or gating mechanisms or by improper trafficking of the protein to the plasma membrane.
Assuntos
Proteínas do Olho/genética , Degeneração Macular/genética , Proteínas Mutantes/genética , Idade de Início , Substituição de Aminoácidos , Bestrofinas , Linhagem Celular , Criança , Pré-Escolar , Canais de Cloreto , Cloretos/metabolismo , Análise Mutacional de DNA , Éxons/genética , Feminino , Genes Dominantes , Humanos , Transporte de Íons/genética , Rim , Degeneração Macular/diagnóstico , Masculino , Mutagênese Sítio-Dirigida , Mutação de Sentido Incorreto , Técnicas de Patch-Clamp , Linhagem , Mutação Puntual , Estrutura Terciária de Proteína , Proteínas Recombinantes de Fusão/fisiologia , Análise de Sequência de DNA , Relação Estrutura-Atividade , TransfecçãoRESUMO
Respiratory chain complex I deficiency represents a genetically heterogeneous group of diseases resulting from mutations in mitochondrial or nuclear genes. Mutations have been reported in 13 of the 14 subunits encoding the core of complex I (seven mitochondrial and six nuclear genes) and these result in Leigh or Leigh-like syndromes or cardiomyopathy. In this study, a combination of denaturing high performance liquid chromatography and sequence analysis was used to study the NDUFS3 gene in a series of complex I deficient patients. Mutations found in this gene (NADH dehydrogenase iron-sulphur protein 3), coding for the seventh and last subunit of complex I core, were shown to cause late onset Leigh syndrome, optic atrophy, and complex I deficiency. A biochemical diagnosis of complex I deficiency on cultured amniocytes from a later pregnancy was confirmed through the identification of disease causing NDUFS3 mutations in these cells. While mutations in the NDUFS3 gene thus result in Leigh syndrome, a dissimilar clinical phenotype is observed in mutations in the NDUFV2 and NDUFS2 genes, resulting in encephalomyopathy and cardiomyopathy. The reasons for these differences are uncertain.
Assuntos
Complexo I de Transporte de Elétrons/genética , Doença de Leigh/etiologia , Doença de Leigh/genética , Mutação/genética , NADH Desidrogenase/genética , Subunidades Proteicas/genética , Criança , Complexo I de Transporte de Elétrons/deficiência , Evolução Fatal , Humanos , Proteínas Ferro-Enxofre/deficiência , Proteínas Ferro-Enxofre/genética , Doença de Leigh/enzimologia , Doença de Leigh/patologia , Masculino , NADH Desidrogenase/deficiência , Subunidades Proteicas/deficiênciaRESUMO
PURPOSE: To report three cases of infantile spasms (IS) with an abnormal magnetic resonance imaging signal in the basal ganglia (Leigh-like syndrome), due to T8993G mt DNA mutation. PATIENTS AND RESULTS: The first sign was, at the end of the first year of life, IS in one case and the combination of IS with behavior changes in the two other cases. Video EEG polygraphy demonstrated both spasms and hypsarrhythmia, but no other kind of seizures. Vigabatrin or steroids controlled the spasms with a follow-up of several years. All 3 patients had hyperlactatorrhachia (3.47 to 7 mmol/l). Axial hypotonia and dystonia appeared by the end of the first year of life. As in cases with the NARP mutation and onset later in life, neuropathy and retinopathy could also be demonstrated. DISCUSSION: Although it is well established that symptomatic IS with hypsarrhythmia mainly result from cortical lesions, this epileptic encephalopathy may also be generated by lesions in the basal ganglia without evidence of cortical damage. This finding suggests that West syndrome is likely to be caused by age-related dysfunction at any level of a cortico-putaminal loop of hyperexcitability.
Assuntos
Adenosina Trifosfatases/genética , Gânglios da Base/patologia , DNA Mitocondrial/genética , Expressão Gênica/genética , Imageamento por Ressonância Magnética , Doenças Mitocondriais/complicações , Doenças Mitocondriais/genética , Mutação Puntual/genética , Espasmos Infantis/genética , Espasmos Infantis/patologia , Anticonvulsivantes/uso terapêutico , Gânglios da Base/diagnóstico por imagem , Pré-Escolar , Análise Mutacional de DNA , Diagnóstico Diferencial , Eletroencefalografia , Feminino , Humanos , Lactente , Doença de Leigh/diagnóstico , Doença de Leigh/genética , Doença de Leigh/fisiopatologia , Masculino , ATPases Mitocondriais Próton-Translocadoras , Espasmos Infantis/tratamento farmacológico , Tomografia Computadorizada por Raios XRESUMO
We identified a new Y243S mutation in the X-linked E1 alpha-PDH gene in a patient with pyruvate dehydrogenase complex (PDHc) deficiency. The activity in cultured fibroblasts was very low even in the presence of high thiamine pyrophosphate (TPP) concentrations, indicating that the defect could be due to decreased affinity of PDHc for TPP.
Assuntos
Mutação de Sentido Incorreto/genética , Mutação de Sentido Incorreto/fisiologia , Piruvato Desidrogenase (Lipoamida)/deficiência , Piruvato Desidrogenase (Lipoamida)/genética , Tiamina Pirofosfato/metabolismo , Western Blotting , Células Cultivadas , Fibroblastos , Humanos , Lactente , Masculino , Polimorfismo Conformacional de Fita SimplesRESUMO
We identified three novel VMD2 mutations in patients with Best's macular dystrophy. DHPLC analysis of the 11 VMD2 exons revealed abnormal profiles in exon 8. Direct sequencing showed that these abnormal profiles were due to monoallelic transitions and transversions. We also found three polymorphic sequence changes that have been reported previously and annotated to an online database (http://www.uni-wuerzburg.de/humangenetics/vmd2.html).
Assuntos
Proteínas do Olho/genética , Degeneração Macular/genética , Mutação/genética , Bestrofinas , Estudos de Casos e Controles , Canais de Cloreto , Cromatografia Líquida de Alta Pressão/métodos , DNA/análise , Análise Mutacional de DNA , Feminino , Humanos , Degeneração Macular/patologia , Masculino , Dados de Sequência Molecular , Desnaturação de Ácido Nucleico , Linhagem , Reação em Cadeia da Polimerase , Análise de Sequência de DNARESUMO
UV-A irradiation caused a dose-dependent decrease in cellular oxygen consumption (56%) and ATP content (65%) in human NCTC 2544 keratinocytes, one hour after treatment. This effect was partially reversed by maintaining the irradiated cells in normal culture conditions for 24 h. Using malate/glutamate or succinate as substrates for mitochondrial electron transport, the oxygen uptake of digitonin-permeabilised cells was greatly inhibited following UV-A exposure. These results strongly suggest that UV-A irradiation affects the state 3 respiration of the mitochondria. However, under identical conditions, UV-A exposure did not reduce the mitochondrial transmembrane potential. The antioxidant, vitamin E inhibited UV-A-induced lipid peroxidation, but did not significantly prevent the UV-A-mediated changes in cellular respiration nor the decrease in ATP content, suggesting that these effects were not the result of UV-A dependent lipid peroxidation. UV-A irradiation also led to an increase in MnSOD gene expression 24 hours after treatment, indicating that the mitochondrial protection system was enhanced in response to UV-A treatment. These findings provide evidence that impairment of mitochondrial respiratory activity is one of the early results of UV-A irradiation for light doses much lower than the minimal erythemal dose.
Assuntos
Respiração Celular/efeitos da radiação , Mitocôndrias/efeitos da radiação , Trifosfato de Adenosina/metabolismo , Antioxidantes , Linhagem Celular , Respiração Celular/fisiologia , Humanos , Líquido Intracelular/metabolismo , Membranas Intracelulares/fisiologia , Membranas Intracelulares/efeitos da radiação , Queratinócitos/citologia , Queratinócitos/efeitos da radiação , Potenciais da Membrana/efeitos da radiação , Mitocôndrias/fisiologia , Superóxido Dismutase/metabolismo , Raios UltravioletaRESUMO
Type I oculocutaneous albinism (OCA) is an autosomal recessive disorder caused by the reduction or the absence of tyrosinase (TYR) activity in melanocytes of the skin, hair and eyes. Here we report an analysis of 45 patients with OCA. We found five novel mutations in the tyrosinase gene involved in the pathogenesis of oculocutaneous albinism type IA or type IB (OCA-1A/B) in five unrelated patients. Three mutations are missense mutations (G109R, P205T and H256Y) and two are nucleotide deletions (336-337delCA and 678-680delAGG). One patient is homozygous for the previously known V275F mutation but has an extremely mild OCA phenotype and has no eye features typical of OCA. In several patients we discovered only one or even no mutation in the coding sequence of the TYR gene. Thus, this disease may also result from mutations in non coding regions of the gene or in another gene involved in the biosynthesis of melanin. Hum Mutat 17:352, 2001.
Assuntos
Albinismo/enzimologia , Albinismo/genética , Monofenol Mono-Oxigenase/genética , Mutação/genética , Albinismo/classificação , Animais , Análise Mutacional de DNA , Éxons/genética , Feminino , Genes Recessivos/genética , Heterozigoto , Humanos , Masculino , Melaninas/biossíntese , Melaninas/genética , Mutação de Sentido Incorreto/genética , Linhagem , Polimorfismo de Fragmento de RestriçãoRESUMO
Cytochrome c oxidase (COX) deficiency is one of the major causes of Leigh Syndrome (LS), a fatal encephalopathy of infancy or childhood, characterized by symmetrical lesions in the basal ganglia and brainstem. Mutations in the nuclear genes encoding COX subunits have not been found in patients with LS and COX deficiency, but mutations have been identified in SURF1. SURF1 encodes a factor involved in COX biogenesis. To date, 30 different mutations have been reported in 40 unrelated patients. We aim to provide an overview of all known mutations in SURF1, and to propose a common nomenclature. Twelve of the mutations were insertion/deletion mutations in exons 1, 4, 6, 8, and 9; 10 were missense/nonsense mutations in exons 2, 4, 5, 7, and 8; and eight were detected at splicing sites in introns 3 to 7. The most frequent mutation was 312_321del 311_312insAT which was found in 12 patients out of 40. Twenty mutations have been described only once. We also list all polymorphisms discovered to date.
Assuntos
Deficiência de Citocromo-c Oxidase , Doença de Leigh/genética , Mutação/genética , Proteínas/genética , Terminologia como Assunto , Sequência de Aminoácidos , Sequência de Bases , Análise Mutacional de DNA , Complexo IV da Cadeia de Transporte de Elétrons/genética , Éxons/genética , Frequência do Gene , Testes Genéticos , Humanos , Íntrons/genética , Doença de Leigh/diagnóstico , Doença de Leigh/enzimologia , Proteínas de Membrana , Proteínas Mitocondriais , Dados de Sequência Molecular , Polimorfismo Genético/genética , Proteínas/química , Sítios de Splice de RNA/genéticaRESUMO
ABSTRACT We report five novel VMD2 mutations in Best's macular dystrophy patients (S16F, I73N, R92H, V235L, and N296S). An SSCP analysis of the VMD2 11 exons revealed electrophoretic mobility shifts exclusively in exons 2, 3, 4, 6 and 8. Direct sequencing indicated that these shifts are caused by mono-allelic transition in exons 2, 4, 6, 8 and transversion in exons 3 and 6. Five novel "silent" polymorphisms are also reported: 213T>C, 323C>A, 1514A>G, 1661C>T, and 1712T>C. Hum Mutat 17:235, 2001.
Assuntos
Proteínas do Olho/genética , Degeneração Macular/genética , Sequência de Bases , Bestrofinas , Canais de Cloreto , DNA/química , DNA/genética , Análise Mutacional de DNA , Saúde da Família , Feminino , Humanos , Degeneração Macular/patologia , Masculino , Mutação , Mutação de Sentido Incorreto , LinhagemRESUMO
The gene SURF1 encodes a factor involved in the biogenesis of cytochrome c oxidase, the last complex in the respiratory chain. Mutations of the SURF1 gene result in Leigh syndrome and severe cytochrome c oxidase deficiency. Analysis of seven unrelated patients with cytochrome c oxidase deficiency and typical Leigh syndrome revealed different SURF1 mutations in four of them. Only these four cases had associated demyelinating neuropathy. Three mutations were novel splicing-site mutations that lead to the excision of exon 6. Two different novel heterozygous mutations were found at the same guanine residue at the donor splice site of intron 6; one was a deletion, whereas the other was a transition [588+1G>A]. The third novel splicing-site mutation was a homozygous [516-2_516-1delAG] in intron 5. One patient only had a homozygous polymorphism in the middle of the intron 8 [835+25C>T]. Western blot analysis showed that Surf1 protein was absent in all four patients harboring mutations. Our studies confirm that the SURF1 gene is an important nuclear gene involved in the cytochrome c oxidase deficiency. We also show that Surf1 protein is not implicated in the assembly of other respiratory chain complexes or the pyruvate dehydrogenase complex.
Assuntos
Doença de Leigh/genética , Mutação , Proteínas/genética , Splicing de RNA , Sequência de Bases , Primers do DNA , Feminino , Heterozigoto , Homozigoto , Humanos , Lactente , Masculino , Proteínas de Membrana , Proteínas MitocondriaisRESUMO
The RCS rat presents an autosomal recessive retinal pigment epithelium dystrophy characterized by the outer segments of photoreceptors being phagocytosis-deficient. A systematic genetic study allowed us to restrict the interval containing the rdy locus to that between the markers D3Mit13 and D3Rat256. We report the chromosomal localization of the rat c-mer gene in the cytogenetic bands 3q35-36, based on genetic analysis and radiation hybrid mapping. Using a systematic biocomputing analysis, we identified two strong related candidate genes encoding protein tyrosine kinase receptors of the AXL subfamily. The comparison of their expression patterns in human and mice tissues suggested that the c-mer gene was the best gene to screen for mutations. RCS rdy- and RCS rdy+ cDNAs were sequenced. The RCS rdy- cDNAs carried a significant deletion in the 5' part of the coding sequence of the c-mer gene resulting in a shortened aberrant transcript encoding a 20 amino acid peptide. The c-mer gene contains characteristic motifs of neural cell adhesion. A ligand of the c-mer receptor, Gas6, exhibits antiapoptotic properties.
Assuntos
Homozigoto , Proteínas Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/genética , Receptores Proteína Tirosina Quinases , Doenças Retinianas/genética , Deleção de Sequência/genética , Sequência de Aminoácidos , Animais , Apoptose/genética , Sequência de Bases , Adesão Celular/genética , Mapeamento Cromossômico , Cruzamentos Genéticos , Eletrorretinografia , Angiofluoresceinografia , Genes Recessivos , Genótipo , Endogamia , Dados de Sequência Molecular , Especificidade de Órgãos/genética , Fenótipo , RNA Mensageiro/genética , Ratos , Ratos Endogâmicos BN , Ratos Mutantes , Doenças Retinianas/etiologia , Análise de Sequência de DNA , c-Mer Tirosina QuinaseRESUMO
Succinate dehydrogenase (SDH) deficiency represents a minor cause of Leigh syndrome (LS). Noticeably, the first mutation in a nuclear-encoded respiratory chain component, a mutation in the 5p15 copy of the flavoprotein (Fp) subunit gene of the SDH, was reported 4 years ago in two siblings with LS and SDH deficiency. We now report a new patient with LS and SDH deficiency. Because two copies of the Fp gene are present in the human genome, we first determined the complete structure of these two copies. This allowed us to identify a 1 bp deletion creating a frameshift in the 3q29 copy, confirming that this second copy was a pseudogene. We also sequenced the promoter region of the 5p 15 gene and, in addition, screened for mutations in the patient. Sequencing of the Fp SDH cDNA in the patient only allowed us to identify a heterozygous C to T transition, changing an alanine to a valine in one allele. This transition was found to be heterozygous in the patient's father but was absent from 150 controls. Transfection of the corresponding mutant cDNA into human Fp-deficient cells failed to restore normal SDH activity, confirming the deleterious effect of this mutation. The second allele, inherited from the mother, carried an A to C substitution changing the methionine translation initiation codon to a leucine. This mutant transcript represented only 10% of total Fp transcript suggesting instability of this transcript. So far, profound deficiencies in complex II activity resulting from mutations in the Fp gene of the SDH present only as LS, a striking observation in view of the ubiquitous expression of this typical housekeeping gene in humans.
Assuntos
Flavoproteínas/genética , Heterozigoto , Doença de Leigh/genética , Complexos Multienzimáticos/genética , Mutação , Oxirredutases/genética , Succinato Desidrogenase/genética , Sequência de Bases , DNA , Transporte de Elétrons , Complexo II de Transporte de Elétrons , Éxons , Feminino , Humanos , Lactente , Íntrons , Dados de Sequência Molecular , Regiões Promotoras GenéticasRESUMO
Expression of the inducible isoform of nitric oxide synthase (iNOS) is stimulated by cytokines in human epithelial cells. This work indicates that incubation of human umbilical cord endothelial cells with combinations of interleukin-1beta, tumor necrosis factor alpha, and interferon-gamma stimulated the synthesis of iNOS mRNA, as detected by reverse transcriptase-polymerase chain reaction. It is important to note that 50, 100, and 200 microM hydrogen peroxide was able to stimulate iNOS directly. Furthermore, 100 microM H2O2 enhanced synthesis of the oxidation products, nitrite (NO2-) and nitrate (NO3-) at 12 and 36 h. iNOS protein, detected by Western blot analysis, as well as L-citrulline levels, were also increased. When endothelial cell monolayers were incubated for 1 h with 100 microM H2O2 and subsequently with cytokines, iNOS mRNA was further augmented. Under the same conditions, we regularly observed an inhibition (25%) of intercellular adhesion molecule-1 (ICAM-1/CD54) expression. The latter was reversed when the NOS inhibitor N(G)-monomethyl-L-arginine was added, as shown by flow cytometry. These data suggest a specific effect of endogenous hydroperoxides on the biosynthesis and processing of the human endothelial iNOS isoform. We propose that H2O2 induces a temporary NO-dependent modulation of adhesion molecule expression to limit the tissue destruction that accompanies the vascular recruitment of leukocytes.
Assuntos
Endotélio Vascular/efeitos dos fármacos , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Molécula 1 de Adesão Intercelular/metabolismo , Óxido Nítrico Sintase/metabolismo , Células Cultivadas , Citrulina/metabolismo , Sinergismo Farmacológico , Endotélio Vascular/citologia , Endotélio Vascular/enzimologia , Endotélio Vascular/imunologia , Humanos , Molécula 1 de Adesão Intercelular/genética , Interferon gama/farmacologia , Interleucina-1/farmacologia , Isoenzimas/antagonistas & inibidores , Isoenzimas/genética , Isoenzimas/metabolismo , Lipopolissacarídeos/farmacologia , NG-Nitroarginina Metil Éster/farmacologia , Nitratos/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase Tipo II , Nitritos/metabolismo , Oxirredução/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
We have previously reported a genetic study of a neonatal lactic acidosis linked to a pyruvate dehydrogenase complex deficiency due to the absence of the protein X subunit. This rare autosomal recessive disorder is associated with specific deletions in this polypeptide which is encoded by the HsPDX1 gene, located on chromosome 11p1.3. The pathology of the patient was considered to arise from a large homozygous deletion (78del85) found at the 5' end of the HsPDX1 coding sequence. Her heterozygous mother underwent prenatal diagnosis during a subsequent pregnancy. Chorionic villus samples were used for three independent studies: (1) normal levels of the protein X component of the PDH complex were detected by immunoblotting; (2) RT-PCR analysis showed no deletion at the 5' end of the cDNA but the presence of a distinct heterozygous deletion (965del59) at its 3' end inherited from the father; (3) haplotype analysis revealed the presence of the father's mutated allele and the mother's normal allele. It was concluded that the fetus was heterozygous for this separate 3' deletion, so, it was likely to be not affected. This study permitted us to characterize more precisely the genetic abnormalities of the HsPDX1 cDNA occurring in each family's member.
Assuntos
Aberrações Cromossômicas/diagnóstico , Cromossomos Humanos Par 11 , Doença de Leigh/diagnóstico , Doença da Deficiência do Complexo de Piruvato Desidrogenase , Western Blotting , Amostra da Vilosidade Coriônica , Transtornos Cromossômicos , Primers do DNA , DNA Complementar/análise , Diagnóstico Diferencial , Feminino , Deleção de Genes , Haplótipos , Humanos , Recém-Nascido , Mutação , Linhagem , Gravidez , Complexo Piruvato Desidrogenase/genética , RNA/genética , RNA/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Recent work has focused attention on the role of oxidative stress in various acute and chronic neurodegenerative diseases. Low concentrations of the powerful antioxidant glutathione (GSH) and impaired brain energy metabolism, particularly in the substantia nigra, are key features of Parkinson's disease (PD). The main goal of this study was to better characterize the deleterious effects of brain GSH depletion on mitochondrial function. We depleted GSH in the brains of newborn wild-type (WT) and transgenic (Tg) mice overproducing either human Cu/Zn-superoxide dismutase (h-CuZnSOD) or human Bcl2 (h-Bcl-2), by subcutaneous injection of l-buthionine sulfoximine (BSO), a specific inhibitor of gamma-glutamylcysteine synthetase. GSH was 97% depleted in brain homogenates and 90% depleted in brain mitochondria for both WT and Tg mice. This depletion of brain GSH led to a decrease in the activity of the GSH-dependent antioxidant enzyme glutathione peroxidase, both in WT and in Tg animals. BSO treatment decreased the activities of respiratory complexes I, II, and IV in the brain homogenates of WT mice. BSO-treated h-CuZnSOD or h-Bcl-2 Tg mice had no respiratory chain deficiencies. Thus, brain GSH depletion leads to the impairment of mitochondrial respiratory chain activity. The protection of mitochondrial respiratory function by overproduction of Bcl-2 may result from a decrease in the generation of reactive oxygen species (ROS) or lipid peroxidation. The protection of mitochondria by overproduction of CuZnSOD is consistent with the involvement of superoxide or superoxide-derived ROS in the mitochondrial dysfunction caused by brain GSH depletion. This study demonstrates that the antioxidant balance is critical for maintenance of brain mitochondrial function, and its disruption may contribute to the pathogenesis of PD.
Assuntos
Encéfalo/metabolismo , Butionina Sulfoximina/farmacologia , Glutationa/metabolismo , Mitocôndrias/metabolismo , Consumo de Oxigênio/fisiologia , Proteínas Proto-Oncogênicas c-bcl-2/genética , Superóxido Dismutase/genética , Animais , Glutamato-Cisteína Ligase/antagonistas & inibidores , Glutationa/antagonistas & inibidores , Humanos , Peroxidação de Lipídeos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Camundongos Transgênicos , Mitocôndrias/efeitos dos fármacos , Consumo de Oxigênio/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/metabolismoRESUMO
UNLABELLED: Succinate dehydrogenase (SDH) deficiency is rare. Clinical manifestations can appear in infancy with a marked impairment of psychomotor development with pyramidal signs and extrapyramidal rigidity. CASE REPORT: A 10-month-old boy developed severe neurological features, evoking a Leigh syndrome; magnetic resonance imaging showed features of leukodystrophy. A deficiency in the complex II respiratory chain (succinate dehydrogenase [SDH]) was shown. The course was remarkable by the regression of neurological impairment under treatment by riboflavin. The delay of psychomotor development, mainly involving language, was moderate at the age of 5 years. CONCLUSION: The relatively good prognosis of this patient, despite severe initial neurological impairment, may be due to the partial enzyme deficiency and/or riboflavin administration.
Assuntos
Encefalopatias/etiologia , Doença de Leigh/etiologia , Riboflavina/uso terapêutico , Succinato Desidrogenase/deficiência , Doenças dos Gânglios da Base/etiologia , Encefalopatias/tratamento farmacológico , Encefalopatias/fisiopatologia , Linguagem Infantil , Pré-Escolar , Seguimentos , Humanos , Lactente , Transtornos da Linguagem/etiologia , Doença de Leigh/tratamento farmacológico , Doença de Leigh/fisiopatologia , Imageamento por Ressonância Magnética , Masculino , Prognóstico , Desempenho Psicomotor/fisiologia , Tratos Piramidais/fisiopatologia , Indução de RemissãoAssuntos
Anormalidades Múltiplas/genética , Citrulina/sangue , DNA Mitocondrial , Mutação , Anormalidades Múltiplas/sangue , Ataxia/genética , Biomarcadores , Pré-Escolar , Feminino , Glicina/genética , Humanos , Lactente , Masculino , Doenças Musculares/genética , Retinose Pigmentar/genética , Treonina/genéticaRESUMO
A growing number of mutated mitochondrial tRNA genes have been found associated with severe human diseases. To investigate the potential interference of such mutations with the primordial function of tRNAs, i.e. their aminoacylation by cognate aminoacyl-tRNA synthetases, a human mitochondrial in vitro aminoacylation system specific for isoleucine has been established. Both native tRNAIleand isoleucyl-tRNA synthetase activity have been recovered from human placental mitochondria and the kinetic parameters of tRNA aminoacylation determined. The effect of pathological point mutations present in the mitochondrial gene encoding tRNAIlehas been tackled by investigating the isoleucylation properties of wild-type and mutated in vitro transcripts. Data show that: (i) modified nucleotides contribute to efficient isoleucylation; (ii) point mutation A4269G in the gene (A-->G at nt 7 in the tRNA), associated with a cardiomyopathy, does not affect aminoacylation significantly; (iii) point mutation A4317G (A-->G at nt 59 in the tRNA), reported in a case of fatal infantile cardiomyopathy, induces a small but significant decrease in isoleucylation. The potential implications of these findings on the understanding of the molecular mechanisms involved in the expression of pathology are discussed.
Assuntos
Isoleucina-tRNA Ligase/metabolismo , Mitocôndrias/metabolismo , Miopatias Mitocondriais/genética , Mutação Puntual , RNA de Transferência de Isoleucina/biossíntese , RNA de Transferência de Isoleucina/genética , Transcrição Gênica , Adenina , Sequência de Bases , Feminino , Guanina , Humanos , Isoleucina-tRNA Ligase/isolamento & purificação , Cinética , Dados de Sequência Molecular , Placenta/metabolismo , Gravidez , RNA/biossíntese , RNA/genética , RNA/isolamento & purificação , RNA Mitocondrial , RNA de Transferência de Isoleucina/químicaRESUMO
We report severe coenzyme Q10 deficiency of muscle in a 4-year-old boy presenting with progressive muscle weakness, seizures, cerebellar syndrome, and a raised cerebro-spinal fluid lactate concentration. State-3 respiratory rates of muscle mitochondria with glutamate, pyruvate, palmitoylcarnitine, and succinate as respiratory substrates were markedly reduced, whereas ascorbate/N,N,N',N'-tetramethyl-p-phenylenediamine were oxidized normally. The activities of complexes I, II, III and IV of the electron transport chain were normal, but the activities of complexes I+III and II+III, both systems requiring coenzyme Q10 as an electron carrier, were dramatically decreased. These results suggested a defect in the mitochondrial coenzyme Q10 content. This was confirmed by the direct assessment of coenzyme Q10 level by high-performance liquid chromatography in patient's muscle homogenate and isolated mitochondria, revealing levels of 16% and 6% of the control values, respectively. We did not find any impairment of the respiratory chain either in a lymphoblastoid cell line or in skin cultured fibroblasts from the patient, suggesting that the coenzyme Q10 depletion was tissue-specific. This is a new case of a muscle deficiency of mitochondrial coenzyme Q in a patient suffering from an encephalomyopathy.